Alexander Zipprich Selected Research

Alexander Zipprich Research Topics

Disease

30	Fibrosis (Cirrhosis) 02/2024 - 02/2003
11	Hemorrhage 10/2023 - 01/2013
9	Ascites 10/2023 - 07/2010
9	Hepatic Encephalopathy 01/2023 - 03/2013
9	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 08/2010
8	Portal Hypertension 10/2023 - 10/2015
7	Liver Diseases (Liver Disease) 01/2023 - 01/2014
5	Infections 10/2023 - 01/2014
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2015
4	Bacterial Infections (Bacterial Infection) 10/2021 - 01/2019
3	Hepatorenal Syndrome 10/2023 - 07/2019
3	Thrombosis (Thrombus) 10/2023 - 10/2015
3	Acute-On-Chronic Liver Failure 04/2023 - 03/2013
3	Inflammation (Inflammations) 01/2023 - 10/2015
2	Liver Failure 01/2022 - 10/2015
2	Esophageal and Gastric Varices (Esophageal Varices) 10/2021 - 09/2015
2	End Stage Liver Disease 01/2020 - 10/2015
2	Peritonitis 07/2019 - 01/2019
2	Neoplasms (Cancer) 01/2019 - 10/2015
2	Brain Diseases (Brain Disorder) 01/2019 - 09/2015
1	Hyponatremia 10/2023
1	Ileus 10/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2023
1	Acute Kidney Injury (Acute Renal Failure) 04/2023
1	Hepatitis B 01/2023
1	Acute-Phase Reaction 01/2023
1	Chronic Hepatitis B 01/2023
1	Hepatitis C 10/2022
1	Multiple Organ Failure (MODS) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Adenoma (Adenomas) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Heart Diseases (Heart Disease) 01/2020
1	Fatty Liver 05/2019
1	Insulin Resistance 05/2019
1	Jaundice (Icterus) 01/2019
1	Splenomegaly 01/2018
1	Hypoxia (Hypoxemia) 01/2018

Drug/Important Bio-Agent (IBA)

4	AlbuminsIBA 04/2020 - 03/2013
3	BilirubinIBA 01/2022 - 10/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
2	Antiviral Agents (Antivirals)IBA 02/2024 - 01/2014
2	SodiumIBA 10/2023 - 07/2010
2	NucleotidesIBA 01/2023 - 01/2019
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2018
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	Lactoylglutathione LyaseIBA 01/2019 - 01/2017
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2018 - 12/2017
2	Adenosine (Adenocard)FDA LinkGeneric 08/2010 - 02/2003
1	Cytidine Triphosphate (CTP)IBA 10/2023
1	CreatinineIBA 10/2023
1	galacturonic acidIBA 08/2023
1	hexanoylcarnitineIBA 08/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Hepatitis B e AntigensIBA 01/2023
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023
1	AmmoniaIBA 01/2023
1	EndotoxinsIBA 01/2023
1	Lipopolysaccharide ReceptorsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 10/2022
1	TeaIBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021
1	Endothelin A ReceptorIBA 01/2021
1	Endothelins (Endothelin)IBA 01/2021
1	theasinensin AIBA 01/2020
1	Vasoconstrictor AgentsIBA 07/2019
1	EndocannabinoidsIBA 05/2019
1	Glucose (Dextrose)FDA LinkGeneric 05/2019
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 05/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	4-(3-chlorophenylsulfanyl)piperidineIBA 01/2019
1	Cell-Free Nucleic AcidsIBA 04/2018
1	Lysine (L-Lysine)FDA Link 02/2018
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Eplerenone (Inspra)FDA LinkGeneric 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	LigandsIBA 01/2018
1	Mineralocorticoid Receptor AntagonistsIBA 01/2018
1	AnticoagulantsIBA 01/2018
1	CollagenIBA 12/2017

Therapy/Procedure

14	Surgical Portasystemic Shunt (Portosystemic Shunt) 02/2024 - 01/2013
11	Therapeutics 02/2024 - 01/2013
9	Transjugular Intrahepatic Portasystemic Shunt 11/2023 - 01/2013
4	Contraindications 10/2023 - 01/2020
2	Liver Transplantation 11/2023 - 01/2023
2	Ligation 10/2023 - 01/2018
2	Stents 01/2020 - 09/2015
1	Catheters 10/2023
1	Conservative Treatment 01/2023
1	Cardiac Catheters 12/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Antibiotic Prophylaxis 01/2021
1	Withholding Treatment 12/2017